The role of cancer in marijuana and prescription opioid use in the United States: A population-based analysis from 2005 to 2014.

Published on Jul 1, 2019in Cancer5.742
· DOI :10.1002/CNCR.32059
Kathryn R. Tringale11
Estimated H-index: 11
(UCSD: University of California, San Diego),
Minh-Phuong Huynh-Le10
Estimated H-index: 10
(UCSD: University of California, San Diego)
+ 3 AuthorsJona A. Hattangadi-Gluth23
Estimated H-index: 23
(UCSD: University of California, San Diego)
BACKGROUND: For patients with cancer, marijuana may be an alternative to prescription opioid analgesics. This study analyzed self-reported marijuana and prescription opioid use among people with cancer over a 10-year time period. METHODS: Population-based data sets from the US National Health and Nutrition Examination Survey between 2005 and 2014 were compiled for respondents aged 20 to 60 years. Respondents with cancer and respondents without cancer were propensity score-matched (1:2) by demographics to compare substance use. Outcomes included current marijuana and prescription opioid use (ie, within the past 30 days). Pearson chi-square tests and logistic regressions were performed; a 2-tailed P value < .05 was significant. RESULTS: There were 19,604 respondents, and 826 people with cancer were matched to 1652 controls. Among the respondents with cancer, 40.3% used marijuana within the past year, and 8.7% used it currently. Respondents with cancer were significantly more likely to use prescription opioids (odds ratio [OR], 2.43; 95% CI, 1.68-3.57; P < .001). Cancer was not associated with current marijuana use in a multivariable conditional logistic regression but was associated with current opioid use (OR, 1.82; 95% CI, 1.17-2.82; P = .008). Among all survey respondents, the odds of marijuana use significantly increased over time (OR, 1.05; 95% CI, 1.01-1.10; P = .012), whereas the odds of opioid use did not significantly change. There were no significant differences in the longitudinal odds of marijuana or opioid use over time between respondents with a cancer diagnosis and those without one. CONCLUSIONS: This population-based analysis revealed a considerable proportion of respondents with cancer self-reporting marijuana use (40.3%) and a significantly higher prevalence of opioid use among respondents with cancer. In the midst of an opioid epidemic, an evolving political landscape, and new developments in oncology, quantifying the prevalence of opioid and marijuana use in the US population, especially among patients with cancer, is particularly relevant. Although opioid use did not significantly change from 2005 to 2014 among all respondents, marijuana use did increase, likely reflecting increased availability and legislative changes. A cancer diagnosis did not significantly affect longitudinal opioid or marijuana use.
📖 Papers frequently viewed together
30 Citations
1 Citations
61 Citations
#1Hefei Wen (UK: University of Kentucky)H-Index: 19
#2Jason M. Hockenberry (Emory University)H-Index: 27
Importance Overprescribing of opioids is considered a major driving force behind the opioid epidemic in the United States. Marijuana is one of the potential nonopioid alternatives that can relieve pain at a relatively lower risk of addiction and virtually no risk of overdose. Marijuana liberalization, including medical and adult-use marijuana laws, has made marijuana available to more Americans. Objective To examine the association of state implementation of medical and adult-use marijuana laws ...
114 CitationsSource
#1Bethann Scarborough (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 3
#2Cardinale B. Smith (Mount Sinai Health System)H-Index: 1
: Pain is a common symptom among patients with cancer. Adequate pain assessment and management are critical to improve the quality of life and health outcomes in this population. In this review, the authors provide a framework for safely and effectively managing cancer-related pain by summarizing the evidence for the importance of controlling pain, the barriers to adequate pain management, strategies to assess and manage cancer-related pain, how to manage pain in patients at risk of substance us...
61 CitationsSource
#1John Pang (UCSD: University of California, San Diego)H-Index: 14
#2Kathryn R. Tringale (UCSD: University of California, San Diego)H-Index: 11
Last. Joseph A. Califano (UCSD: University of California, San Diego)H-Index: 89
view all 14 authors...
Importance Opioid misuse and overuse has become an epidemic. Chronic opioid use among oral cavity cancer patients after surgery has not been described. Objectives To assess the prevalence of chronic opioid use in patients undergoing surgery for oral cavity cancer, and evaluate possible associated clinical factors; and the association between opioid use and survival. Design, Setting, and Participants For this retrospective cohort study of patients undergoing surgery for oral cavity cancer a conse...
36 CitationsSource
#7Jesse R. Fann (WashU: Washington University in St. Louis)H-Index: 51
BACKGROUND Cannabis is purported to alleviate symptoms related to cancer treatment, although the patterns of use among cancer patients are not well known. This study was designed to determine the prevalence and methods of use among cancer patients, the perceived benefits, and the sources of information in a state with legalized cannabis. METHODS A cross-sectional, anonymous survey of adult cancer patients was performed at a National Cancer Institute–designated cancer center in Washington State. ...
75 CitationsSource
#1J.S. Lee (UM: University of Michigan)H-Index: 2
#2Hsou Mei Hu (UM: University of Michigan)H-Index: 18
Last. Lesly A. DossettH-Index: 27
view all 11 authors...
PurposeThe current epidemic of prescription opioid misuse has increased scrutiny of postoperative opioid prescribing. Some 6% to 8% of opioid-naive patients undergoing noncancer procedures develop new persistent opioid use; however, it is unknown if a similar risk applies to patients with cancer. We sought to define the risk of new persistent opioid use after curative-intent surgery, identify risk factors, and describe changes in daily opioid dose over time after surgery.MethodsUsing a national ...
189 CitationsSource
#1Ali Haider (TTSH: Tan Tock Seng Hospital)H-Index: 7
#2Donna S. Zhukovsky (TTSH: Tan Tock Seng Hospital)H-Index: 22
Last. Eduardo BrueraH-Index: 126
view all 13 authors...
Introduction:In the United States, opioid regulations have become increasingly stringent in recent years. Increased regulatory scrutiny, in part, is related to heightened awareness through literature and a recent media blitz on the opioid prescription epidemic. These regulations have the potential to impact prescription trends by health care providers. Our objective was to evaluate changes in the type and dose of opioid prescriptions among patients who are referred by oncologists to an outpatien...
32 CitationsSource
#1Beth HanH-Index: 31
#2Wilson M. ComptonH-Index: 70
Last. Christopher M. JonesH-Index: 43
view all 6 authors...
Despite the continuing epidemic of opioid misuse, data about the prevalence and correlates of misuse are scarce. This study used data from the National Survey on Drug Use and Health to estimate the...
476 CitationsSource
#1Gery P. GuyH-Index: 35
#2Kun ZhangH-Index: 11
Last. Deborah DowellH-Index: 21
view all 8 authors...
BACKGROUND: Prescription opioid-related overdose deaths increased sharply during 1999-2010 in the United States in parallel with increased opioid prescribing. CDC assessed changes in national-level and county-level opioid prescribing during 2006-2015. METHODS: CDC analyzed retail prescription data from QuintilesIMS to assess opioid prescribing in the United States from 2006 to 2015, including rates, amounts, dosages, and durations prescribed. CDC examined county-level prescribing patterns in 201...
637 CitationsSource
#1James M CorroonH-Index: 1
#2Laurie K. Mischley (Bastyr University)H-Index: 9
Last. Michelle SextonH-Index: 11
view all 3 authors...
BACKGROUND: The use of medical cannabis is increasing, most commonly for pain, anxiety and depression. Emerging data suggest that use and abuse of prescription drugs may be decreasing in states where medical cannabis is legal. The aim of this study was to survey cannabis users to determine whether they had intentionally substituted cannabis for prescription drugs. METHODS: A total of 2,774 individuals were a self-selected convenience sample who reported having used cannabis at least once in the ...
106 CitationsSource
#1Philippe Lucas (UVic: University of Victoria)H-Index: 15
#2Zach Walsh (UBC: University of British Columbia)H-Index: 24
Abstract Background In 2014 Health Canada replaced the Marihuana for Medical Access Regulations (MMAR) with the Marihuana for Medical Purposes Regulations (MMPR). One of the primary changes in the new program has been to move from a single Licensed Producer (LP) of cannabis to multiple Licensed Producers. This is the first comprehensive survey of patients enrolled in the MMPR. Methods Patients registered to purchase cannabis from Tilray, a federally authorized Licenced Producer (LP) within the M...
130 CitationsSource
Cited By6
#1Elizabeth K Do (VCU: Virginia Commonwealth University)H-Index: 11
#2Albert J. Ksinan (VCU: Virginia Commonwealth University)H-Index: 7
Last. Bernard F. Fuemmeler (VCU: Virginia Commonwealth University)H-Index: 38
view all 5 authors...
Background Research on cannabis use among those with a history of cancer is limited. Methods Prevalence of past-year cannabis use among individuals with and without a cancer history and predictors of use within these 2 groups were determined using data from the Population Assessment of Tobacco and Health study, a nationally representative, longitudinal survey conducted in the United States (waves 1-4; 2013-2018). Discrete time survival analyses were used to estimate baseline (wave 1) predictors ...
#1Julia Fehniger (SUNY: State University of New York System)
#2Allison L. Brodsky (Gynecologic Oncology Group)
Last. Bhavana Pothuri (Gynecologic Oncology Group)H-Index: 25
view all 4 authors...
Abstract null null Background null Medical marijuana (MM) use is common among cancer patients, but relatively little is known about the usage patterns and efficacy of MM used by gynecologic cancer patients. null null null Methods null Demographic and clinical data were collected for gynecologic cancer patients prescribed MM between May 2016 and February 2019. The electronic medical record was used to query formulation prescribed, usage patterns, length of use, symptom relief, and side effect pro...
#1Richard J. Bodnar (QC: Queens College)H-Index: 66
Abstract This paper is the forty-second consecutive installment of the annual anthological review of research concerning the endogenous opioid system, summarizing articles published during 2019 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides and receptors as well as effects of opioid/opiate agonists and antagonists. The review is subdivided into the following specific topics: molecular-biochemical effects and neurochemical localizatio...
1 CitationsSource
#1Hermine Poghosyan (NU: Northeastern University)H-Index: 8
#2Edward J. Noonan (NU: Northeastern University)
Last. Gary J. Young (NU: Northeastern University)H-Index: 34
view all 5 authors...
Abstract Background Cancer survivors are vulnerable to Cannabis Use (CU) and at increased risk for depression. Yet, the relationship between CU and depression among cancer survivors is unknown. Purpose The purpose of this study was to estimate the prevalence of daily/non-daily CU, investigate the association between CU and depression and evaluate CU reasons and methods of administration among cancer survivors. Method Population-based, nationally representative sample of cancer survivors aged ≥18...
#1Hermine Poghosyan (College of Health Sciences, Bahrain)H-Index: 8
#2Armen Poghosyan (University of Oxford)H-Index: 7
Abstract Introduction More and more U.S. states are legalizing marijuana use for both recreational and medical purposes. This study estimated the prevalence of current marijuana use and identified its individual-level predictors among adult cancer survivors (CS) living in 15 U.S. states and territories. Methods U.S. nationally representative, cross-sectional data from the 2018 Behavioral Risk Factor Surveillance System Survey (BRFSS) Marijuana Use module were used. A total of 9,325 CS was includ...
#1Robert A. Swarm (WashU: Washington University in St. Louis)H-Index: 12
#2Judith A. Paice (NU: Northwestern University)H-Index: 62
Last. Lisa A. Gurski (National Comprehensive Cancer Network)H-Index: 10
view all 30 authors...
: In recent years, the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Adult Cancer Pain have undergone substantial revisions focusing on the appropriate and safe prescription of opioid analgesics, optimization of nonopioid analgesics and adjuvant medications, and integration of nonpharmacologic methods of cancer pain management. This selection highlights some of these changes, covering topics on management of adult cancer pain including pharmacologic interventions, nonpharma...
104 CitationsSource